Nuveen Asset Management, LLC Aprea Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$4.05 - $5.5 $71,138 - $96,607	-17,565 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.73 - $8.15 $78,953 - $136,039	-16,692 Reduced 48.73%	17,565 $90,000
Q4 2020 Feb 16, 2021	BUY	$4.92 - $30.67 $28,634 - $178,499	5,820 Added 20.47%	34,257 $169,000
Q3 2020 Nov 16, 2020	SELL	$21.66 - $38.86 $76,178 - $136,670	-3,517 Reduced 11.01%	28,437 $685,000
Q2 2020 Aug 14, 2020	BUY	$25.47 - $39.69 $265,881 - $414,323	10,439 Added 48.52%	31,954 $1.24 Million
Q1 2020 May 14, 2020	BUY	$31.65 - $45.3 $126,853 - $181,562	4,008 Added 22.89%	21,515 $747,000
Q4 2019 Feb 14, 2020	BUY	$18.94 - $49.53 $331,582 - $867,121	17,507 New	17,507 $803,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,688
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.